<DOC>
	<DOCNO>NCT01133509</DOCNO>
	<brief_summary>In pilot study , intend demonstrate great portion woman high risk ( inadequate screening , HPV 16/18 and/or cytology ) present ED , cytology/ HPV test via ThinPrep®Pap testTM surveillance . We intend provide improve access healthcare monitor administration vaccine eligible patient 1 year follow patient involve study . Females meet inclusion/exclusion criterion participate study ( n=100 ) cytology test 2 year offer Thin Prep® cytology test . This study allow surveillance disease cytology HPV DNA test via collection data use Thin Prep® cytology reflex HPV DNA test accord establish guideline describe . Provide improve access healthcare monitor administration vaccine eligible female establish guideline . Patients receive first vaccine ED arrange follow administration 2 month 6 month series HPV vaccination . Through data collection , intend determine need vaccination determine patient likely follow up..</brief_summary>
	<brief_title>A Model Implementation Cervical Cancer Screening HPV Vaccination Emergency Department : Pilot Study</brief_title>
	<detailed_description />
	<mesh_term>Emergencies</mesh_term>
	<mesh_term>Uterine Cervical Neoplasms</mesh_term>
	<mesh_term>Virus Diseases</mesh_term>
	<mesh_term>Papilloma</mesh_term>
	<mesh_term>Papillomavirus Infections</mesh_term>
	<criteria>3 year begin sexual activity age 21 year whichever occur first . resident City Norfolk , Virginia uninsured Pregnant woman Women Hysterectomy cervical excision Women receive full HPV vaccine series Known history cervical cancer Male sex Loop electrocautery excision procedure ( LEEP ) ColdKnife conization</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>26 Years</maximum_age>
	<verification_date>August 2012</verification_date>
</DOC>